http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b712a0c707f459d0fc22b83a1711bb95
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Hamel |
| name | Ernest Hamel |
| given-name | Ernest |
| organization-name | Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Indiana 47907, Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702, and Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of... Department of Medicinal Chemistry, University of Utah, Salt Lake City, Utah 84112, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702 Natural Products Laboratory, Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, Graduate Institute of Pharmaceutical Chemistry, China Medical College, Taichung 400, Taiwan, Republic of China, Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research Center, Frederick,... Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, P.O. Box 872404, Tempe, Arizona 85287-2404, Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702-1201, and SAIC-Frederick, Inc., Frederick, Maryland 21702 Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, and Department of Chemistry, Purdue University, West Lafayette, Indiana 47907, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702 Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, P.O. Box 872404, Tempe, Arizona 85287-2404, Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, University of Bradford, Cancer Research Unit, West Yorkshire BD7 1DP, United Kingdom, and Science Applications International Corp., National Cancer Institute... Istituto Pasteur - Fondazione Cenci Bolognetti, Dipartimento di Studi Farmaceutici, Università di Roma “La Sapienza”, Piazzale Aldo Moro 5, I-00185 Roma, Italy, Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff, CF10 3XF, UK, Program in Cell Biology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at... Screening Technologies Branch, Developmental Therapeutics Program, National Cancer Institute, Frederick National Laboratory of Cancer Research, National Institutes of Health, Frederick, Maryland 21702, United States Laboratory of Molecular Pharmacology, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, and Department of Surgical Research, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115 Department of Chemistry, The Faculties, Australian National University, Canberra, ACT, 0200, Australia, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702 Graduate Institute of Pharmaceutical Chemistry, China Medical College, Taichung, Taiwan, Natural Products Laboratory and Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702 Laboratory of Molecular Genetics, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20014 Target Structure-Based Drug Discovery Group, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland 21702, United States, Departments of Chemistry and Medicinal Chemistry, Purdue University, West Lafayette, Indiana 47907, United States, and Information Technology Branch and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702... Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, P.O. Box 872404, Tempe, Arizona 85287-2404, and Laboratory of Drug Discovery Research and Development and Screening Technologies Branch, DTP/DCTD, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201 2Screening Technologies Branch, Developmental Therapeutic Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Frederick, Maryland; Screening Technologies Branch, Developmental Therapeutics Program Division of Cancer Treatment and Diagnosis Frederick National Laboratory for Cancer Research National Cancer Institute National Institutes of Health Frederick MD 21702 USA Cancer Research Institute and Department of Chemistry, Arizona State University, Tempe, Arizona 85287-1604 Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Indiana 47907, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702 Dipartimento di Scienze Farmaceutiche, Università di Ferrara, Via Fossato di Mortara 17-19, 44100 Ferrara, Italy, R & D, Sigma-Tau, Pomezia, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Bologna, Italy, Dipartimento Farmacochimico Tossicologico e Biologico, Università di Palermo, Palermo, Italy, Cattedra di Ematologia e Servizio AIDS, Policlinico di Palermo, Palermo, Italy, SAIC-Frederick, Inc., Frederick, Maryland 21702, Screening Technologies Branch, Developmental Therapeutics... Department of Pharmaceutical Sciences, University of Antwerp, B-2610 Antwerp, Belgium, Department of Chemistry, University of Antwerp, B-2020 Antwerp, Belgium, Science Applications International CorporationFrederick, Frederick Cancer Research and Development Center, Frederick, Maryland 21702, and Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center,... Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Indiana 47907, Biological Testing Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Fairview Center, Suite 205, 1003 West Seventh Street, Frederick, Maryland 21701, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and... Cancer Research Institute and Department of Chemistry, Arizona State University, P.O. Box 872404, Tempe, Arizona 85287-2404, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702-1201 College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon 97331, Department of Chemistry, Oregon State University, Corvallis, Oregon 97331, Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, and Chemistry Department, University of Hawaii at Monoa,... Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599-7360, Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute,... Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Institutes of Health, 1050 Boyles Street, Frederick, Maryland 21702, United States 2Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, NIH, Frederick, Maryland Cancer Research Institute and Department of Chemistry Arizona State University, Tempe, Arizona 85287-2404, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201 Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, Department of Chemistry, University of California at Irvine, Irvine, California 92697, and Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid 28040, Spain Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, Maryland 21702, United States Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick National Laboratory for Cancer Research, National Institutes of Health, Frederick, Maryland 21702, United States Natural Products Laboratory, Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, China Medical College, Taichung, Taiwan, and Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702 Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, Department of Chemistry, University of Illinois at Chicago, Chicago, Illinois 30322, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Cientificas, 28006 Madrid, Spain, and Science... Department of Environmental and Occupational Health, Department of Pharmaceutical Sciences, and the University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15238, Laboratory of Molecular Pharmacology, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, and Division of Biomedical Marine Research, Harbor Branch Oceanographic Institution, Inc., Fort Pierce, Florida 34946 Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, Department of Chemistry, University of Arizona, Tucson, Arizona 85721, Department of Chemistry, University of Hawaii, Manoa, Hawaii 96822, and Cancer Research Institute and Department of Chemistry, Arizona State University, Tempe, Arizona 85287-1604 Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, and Department of Chemistry, Purdue University, West Lafayette, Indiana 47907, Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, and EntreMed, Inc., Rockville, Maryland 20850 Cancer Research Institute and Department of Chemistry and Biochemistry, and Department of Microbiology, Arizona State University, Box 872404, Tempe, Arizona 85287-2404; Molecular Mechanisms of Tumor Promotion Section, LCCTP, National Cancer Institute, Bethesda, Maryland 20892-4255; and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702 Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Indiana 47907, Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702 4Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, NIH Natural Products Laboratory and the Laboratory for Molecular Modeling, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, Graduate Institute of Pharmaceutical Chemistry, China Medical College, Taichung 400, Taiwan, Republic of China, Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research Center, Frederick, Maryland 21702 Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, United States Dipartimento di Scienze Farmaceutiche, Università di Ferrara, 44100 Ferrara, Italy, SAIC-Frederick Inc., National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, ER-GenTech, Dipartimento di Biochimica e Biologia Molecolare, Molecular Biology Section,... Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Indiana 47907, Department of Chemistry, University of Illinois, Urbana, Illinois 61801, Drug Synthesis and Chemistry Branch, Developmental Therapeutics Program, Division of Cancer Treatment, Diagnosis and Centers, National Cancer Institute, Executive Plaza North, Suite 831, 6130 Executive Boulevard, Rockville, Maryland 20852, Laboratory of Drug Discovery Research and... Cancer Research Institute and Department of Chemistry, Arizona State University, P.O. Box 872404, Tempe, Arizona 85287-2404, and Laboratory of Drug Discovery Research and Development, DTP/DCTD, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201 Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick Laboratory for Cancer Research, National Institutes of Health, Frederick, Maryland Molecular Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Diagnosis and Treatment, National Cancer Institute, Frederick National Laboratory for Cancer Research, National Institutes of Health, Frederick, Maryland 21702, USA Natural Products Laboratory, Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, Graduate Institute of Pharmaceutical Chemistry, China Medical College, Taichung 400, Taiwan, Republic of China, Drug Synthesis and Chemistry Branch, Developmental Therapeutics Program, Division of Cancer Treatment, Diagnosis and Centers, and Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer... Molecular Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, United States Authors' Affiliations: Schools of 1Biological Sciences and 2Chemical and Physical Sciences, Victoria University of Wellington, Wellington, New Zealand; 3Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, NIH, Frederick, Maryland; and 4Department of Medicine, Division of Hematology/Clinical Oncology, Weill Cornell Medical College, New York Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, P.O. Box 872404, Tempe, Arizona 85287-2404, Screening Technologies Branch, DTP/DCTD, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702-1201, and Molecular Mechanisms of Tumor Promotion Section, LCCTP, National Cancer Institute, Bethesda, Maryland 20892-4255 Authors' Affiliations: 1Target Structure-Based Drug Discovery Group, SAIC-Frederick, Inc., 2Screening Technologies Branch, and 3Information Technology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, NIH, Frederick, Maryland; 4Department of Experimental Oncology, European Institute of Oncology; 5Dipartimento di Scienze Farmaceutiche “Pietro Pratesi”, and 6Dipartimento di Chimica Fisica ed Elettrochimica, Università degli Studi di Milano, Milan, Italy Division of Chemical Therapeutics, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, CRB-I, 162 C, Baltimore, Maryland 21231, Pathology Department, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, Netherlands, Gastrointestinal Cancer Program, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, CRB-I, 162 A, Baltimore, Maryland 21231, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division... Natural Products Laboratory, Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina at Chapel Hill, North Carolina 27599, Graduate Institute of Pharmaceutical Chemistry, China Medical College, Taichung 400, Taiwan, Republic of China, Drug Synthesis and Chemistry Branch, Developmental Therapeutics Program, Division of Cancer Treatment, Diagnosis and Centers, and Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer Institute,... Molecular Pharmacology Branch Developmental Therapeutics Program Division of Cancer Treatment and Diagnosis National Cancer Institute Frederick MD 21702 USA Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Department of Chemistry and Skaggs Institute for Chemical Biology, Scripps Research Institute, La Jolla, California 92037, and Department of Chemistry and Biochemistry, University of California at San Diego, La Jolla, California 92093 Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, Maryland 21702-1201 Natural Products Laboratory, Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, and Department of Chemistry, Paul M. Gross Chemical Laboratory, Duke University, Durham, North Carolina 27708 Division of Chemical Therapeutics, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, and SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland 21702 Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick National Laboratory of Cancer Research, National Institutes of Health, Frederick, Maryland 21702, United States Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702 Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, P.O. Box 872404, Tempe, Arizona 85287-2404, Science Applications International Corp.Frederick, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702-1201, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702-1201 Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702 Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, and the Purdue Cancer Center, Purdue University, West Lafayette, Indiana 47907, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, EntreMed, Inc., Rockville, Maryland 20850, and Department of Chemistry, Purdue University, West Lafayette... Target Structure-Based Drug Discovery Group, Developmental Therapeutics Program, National Cancer Institute, Frederick, Maryland 21702, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, Center for Chemical Methodologies & Library Development, University of Pittsburgh, Pennsylvania 15260, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer... Screening Technologies Branch; Developmental Therapeutics Program; Division of Cancer Treatment and Diagnosis; National Cancer Institute; Frederick National Laboratory for Cancer Research Dipartimento di Scienze Farmaceutiche, Università di Ferrara, 44100 Ferrara, Italy, Divisione di Ematologia e Servizio AIDS, Dipartimento di Oncologia, Policlinico “P. Giaccone”, Università di Palermo, Palermo, Italy, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Minderbroedersstraat 10, B-3000 Leuven, Belgium, Department of Molecular, Cellular and Developmental Biology and Neuroscience Research Institute, University of California Santa Barbara, Santa Barbara, California,... Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick National Laboratory for Cancer Research, National Institutes of Health, Frederick, MD, USA Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Cientificas, 28040 Madrid, Spain, Information Technology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick,... Departments of Pharmaceutical Sciences, Chemistry, and Pharmacology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702 Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick National Laboratory for Cancer Research, Frederick 21702, Maryland, United States Science Applications International Corporation−Frederick, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702 Istituto Pasteur − Fondazione Cenci Bolognetti, Dipartimento di Studi Farmaceutici, Sapienza Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy, Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff, CF10 3XF, United Kingdom, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, Dipartimento di Chimica... Dipartimento di Scienze Farmaceutiche, Università di Ferrara, 44100 Ferrara, Italy, Dipartimento di Oncologia, Divisione di Ematologia e Servizio AIDS, Policlinico “P. Giaccone”, Università di Palermo, Palermo, Italy, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium, Centre for Molecular Drug Design, Cockroft Building, University of Salford, Manchester M5 4W5, U.K., The Welsh School of Pharmacy, Cardiff University, King Edward... Molecular Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland21702, United States 2Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Cancer Institute, Frederick, Maryland; Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, National Institutes of Health, Frederick, Maryland 21702 Department of Chemistry and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702 Dipartimento di Studi Farmaceutici, Università di Roma “La Sapienza”, Piazzale Aldo Moro 5, I-00185 Roma, Italy, Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff, CF10 3XF, U.K., and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702 Department of Chemistry, Oregon State University, Corvallis, Oregon 97331, and Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Maryland 21702 Natural Products Laboratory, Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina at Chapel Hill, North Carolina 27599, and Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702 Department of Chemistry and Biochemistry, P.O. Box 97348, Baylor University, Waco, Texas 76798, Cancer Research Institute and Department of Chemistry, Arizona State University, Tempe, Arizona 85287-1604, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702 Kevin_Pinney@Baylor.edu Department of Chemistry, The Faculties, Australian National University, Canberra, ACT, 0200, Australia, Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, and Science Applications International CorporationFrederick, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702 Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, P.O. Box 872404, Tempe, Arizona 85287-2404, Science Application International CorporationFrederick, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702 Dipartimento di Scienze Farmaceutiche, Università di Ferrara, 44100 Ferrara, Italy, Dipartimento di Oncologia, Policlinico “P. Giaccone”, Divisione di Ematologia e Servizio AIDS, Università di Palermo, Palermo, Italy, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium, The Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff, CF10 3XF, U.K., Division of Biotechnology and Pharmaceutical Research, National... Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, United States Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, P.O. Box 871604, Tempe, Arizona 85287-1604, and DTP, DCTC, NCI, P.O. Box B, Building 469, Room 104, Frederick, Maryland 21702-1201 Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, United States Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702-1201, United States Department of Chemistry, University of Virginia, Charlottesville, Virginia 22904, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia 22908, and Department of Oncology, Drug Discovery Program, Georgetown University Medical Center,... Developmental Therapeutics Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA; |
Incoming Links
Total number of triples: 468.